MacroGenics | MGNX - Ebitda





Ebitda Veränderung Datum
AbbVie USD 6.91B 3.22B 2026-06
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Genmab DKK 401M 186M 2026-06
Geron USD 3.83M 25.12M 2026-03
Gilead Sciences USD -9.31B 12.82B 2026-06
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Pfizer USD 6.01B 18M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Xencor USD -34.63M 86.74M 2026-06